Michael Hall is a corporate partner in Latham & Watkins’ Silicon Valley office. Mr. Hall represents emerging growth companies, both public and private, and has broad experience in:
- Venture capital financing
- Mergers and acquisitions
- Public securities
A former director and founding partner of Venture Law Group, Mr. Hall’s clients range from life science companies to those involved in a variety of technology segments such as software and electronics. He also represents underwriters in public offerings and venture capitalists in private equity financings.
Mr. Hall has taught classes at Stanford and Boalt Hall on representation of technology companies. He was named as one of America’s Leading Business Lawyers in Chambers US 2005, 2006, 2009, 2010, 2011 and 2012, and recognized as a "key partner" for Venture Capital and Emerging Companies in The Legal 500 2012. He was also recently named a "Life Science Star" in LMG LIfe Sciences 2012. Mr. Hall is a member of the board of San Francisco RBI, a non-profit focused on sports and literacy for underprivileged children in San Francisco.
Mr. Hall’s representative clients include:
- Accuray (system for precise delivery of radiation in treatment of cancer)
- ArthroCare (technology and devices for soft-tissue removal)
- Benvenue Medical (devices for spine repair)
- Cardiva (vascular closure devices)
- Conceptus (tools and devices for minimally invasive permanent contraception)
- Eleven Blade Solutions (orthopedic devices)
- Intuity Medical (blood-glucose monitoring devices)
- Medivation (pharmaceuticals)
- Nevro Corp. (devices for pain relief)
- OsteoSpring (orthopedic devices)
- Prometheus Laboratories (diagnostics and therapeutics)
- Siesta Medical (devices for treatment of obstructive sleep apnea)
- Theracos (pharmaceuticals)